Sunzen Biotech Berhad  >  Investor Relations Home
 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 
Welcome to Sunzen Biotech Berhad Investor Relations

Sunzen Group began as a subsidiary of Pfizer, and changed its name to Sunzen Corporation in 1998 under a management buyout exercise. We assumed our present name in 2007.

Equipped with proven expertise in developing new animal health products, and leveraging on our marketing network in Malaysia and the region, we have successfully developed and marketed animal health products under the "Sunzen" brand, as feed additives, nutritional feed supplements, Veterinary pharmaceuticals, Animal vaccines, disinfectants, etc.

Learn More 
 
 
Financial Hightlights

Result for period ended 30.9.2011 3Q11
RM '000
Revenue 7,701
PBT 555
NA per share (RM) 0.20
EPS (sen) 0.29
Stock Quotes


RM 0.210 0.000 0.0 %
 
Latest Annoucements

03 January 2012
OTHERS - Completion of Tenure of Sponsorship pursuant to Rule 3.21(1) of the ACE Market Listing Requirement of Bursa Malaysia Securities Berhad

17 November 2011
Change Of Company Secretary

17 November 2011
Change Of Company Secretary

View All
Quick Links

Annual Report
Download PDF
 
Quarterly Result
Download PDF
 
Email Alerts
 
 
ChartNexus Sdn Bhd © 2012 Privacy Policy | Terms of Use